A study by Kovler et al. (71) demonstrated that enteric glial cell deficiency may promote NEC through TLR4 activation and intestinal motility disorders, suggesting that the repair of enteric glial cells could be a potential therapeutic approach. The gene discussed is TLR4; the disease is necrotizing enterocolitis.